Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Widmer
Andreas F
AF
D002511:Cephalosporins / Q000627:therapeutic use*; D006801:Humans; D016106:Methicillin Resistance; D018461:Soft Tissue Infections / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects*
D002511:Cephalosporins; C443755:ceftobiprole